Prostaglandin derivatives

Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acid esters

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C560S055000, C560S061000, C560S062000, C544S386000, C544S406000, C546S225000, C546S315000, C514S255010, C514S255060

Reexamination Certificate

active

11029698

ABSTRACT:
Prostaglandin nitroderivatives having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.

REFERENCES:
patent: 3922293 (1975-11-01), Morozowich
patent: 4952581 (1990-08-01), Bito et al.
patent: 5625083 (1997-04-01), Bezuglov et al.
patent: 5811443 (1998-09-01), DeSantis, Jr. et al.
patent: 6211233 (2001-04-01), Del Soldato
patent: 6242432 (2001-06-01), Del Soldato
patent: 6417228 (2002-07-01), Klimko
patent: 04100001.9 (2004-01-01), None
patent: WO90/02553 (1990-03-01), None
patent: WO94/10141 (1994-05-01), None
patent: WO98/58910 (1998-12-01), None
patent: WO 00/51978 (2000-09-01), None
patent: WO2005/068421 (2005-07-01), None
Alm, A., Prostaglandin Derivatives As Ocular Hypotensive Agents,Progress In Retinal And Eye Research,1997, 291-312, vol. 17, No. 3.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Prostaglandin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prostaglandin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostaglandin derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3786481

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.